By: Bernard Carroll
Good riddance to Martin Keller. The question is why Brown University joins in his hypocrisy about Study 329. There were indeed “inaccuracies” (ahem) in the published report. One was the flat out claim...
View ArticleBy: Justice in MI
I wouldn’t hold my breath. Unfortunately, this is yet another example of the corruption that is part of academic medicine, especially when the “franchise” is threatened. It’s not all about the football...
View ArticleBy: Michael S. Altus, PhD, ELS
The blog 1 Boring Old Man (http://1boringoldman.com) has been posting extensive entries about Study 329, the most recent at the time of this writing is dated September 4, 2012.
View ArticleBy: Alice
…and the lead author slinks off into the sunset, with not even an admonition from Brown. The new president should be ashamed of herself for splitting hairs. Academic medicine continues to be tarnished...
View ArticleBy: Alice
…and the lead author slinks off into the sunset, with not even an admonition from Brown. The new president should be ashamed of herself for splitting hairs. Academic medicine continues to be tarnished...
View ArticleBy: original industry insider
JiM has the analogy correct. After all the ignominious enabler of child molestation aka Joe Paterno was a Brown alumnus.
View ArticleBy: Evelyn Pringle
In alphabetical order, the full list of authors who signed off on the ghostwritten/fraudulent Paxil Study 329 in 2001, and should be held accountable, includes: Boris Birmaher Gabrielle Carlson Gregory...
View ArticleBy: PharmaDoc
How should new drugs be developed, approved and brought to the market, and who should pay for the R & D costs that are involved? To suggest that Keller’s retirement as Chair is even remotely...
View ArticleBy: Ed Silverman
Hi PharmaDoc, Thanks for the note. Your initial question addresses a raft of issues that have been discussed and debated here, there and everywhere for quite some time. The Senate probe that focused on...
View Article
